WeVote

Bill

Bill

HR 4101

Cancer Drug Parity Act of 2025

119th Congress Introduced by Becca Balint and 20 co-sponsors

The Cancer Drug Parity Act of 2025 ensures insurance covers oral cancer medications equally to IV treatments, reducing costs for patients and improving access to care.

Introduced in House
1

WeVote — Public opinion

No community votes yet. Be the first to weigh in from the Vote tab.

Bill text & amendments

No documents yet

The official bill text and any amendments will be posted here once available.